Literature DB >> 24560583

A far-upstream AP-1/Smad binding box regulates human NOX4 promoter activation by transforming growth factor-β.

Guangxing Bai1, Thomas D Hock1, Naomi Logsdon1, Yong Zhou1, Victor J Thannickal2.   

Abstract

NADPH oxidase 4 (NOX4) is a member of the NADPH oxidase gene family that regulates cellular differentiation, innate immunity and tissue fibrosis. Transforming growth factor-β (TGF-β1) is known to induce expression of NOX4 mRNA in mesenchymal cells. However, the mechanisms of transcriptional regulation of NOX4 are not well understood. In this study, we examined the transcriptional regulation of NOX4 in human lung fibroblasts by TGF-β1. Five promoter-reporter constructs containing DNA fragments of 0.74kb, 1.35kb, 1.84kb, 3.97kb and 4.76kb upstream from the transcriptional start site (TSS) of the human NOX4 gene were generated and their relative responsiveness to TGF-β1 analyzed. TGF-β1-induced NOX4 gene promoter activation requires a region between -3.97kb and -4.76kb. Bioinformatics analysis revealed a 15bp AP-1/Smad binding element in this region. Mutation or deletion of either the AP-1 or the Smad element attenuated TGF-β1 responsiveness of the -4.76kb NOX4 promoter. Furthermore, insertion of this AP-1/Smad box conferred TGF-β1 inducibility to the non-responsive -3.97kb NOX4 promoter construct. Chromatin immunoprecipitation analysis indicated that phospho-Smad3 and cJun associate with this element in a TGF-β1-inducible manner. These results demonstrate that the AP-1/Smad box located between 3.97kb and 4.76kb upstream of the TSS site of the NOX4 promoter is essential for NOX4 gene transcription induced by TGF-β1 in human lung fibroblasts. Our study provides insights into the molecular mechanisms of NOX4 gene expression, informing novel therapeutic approaches to interfere with upregulation of NOX4 in diseases characterized by activation of the TGF-β1/NOX4 pathway. Published by Elsevier B.V.

Entities:  

Keywords:  NADPH Oxidase-4; Pulmonary fibrosis; TGF-β1

Mesh:

Substances:

Year:  2014        PMID: 24560583      PMCID: PMC4009368          DOI: 10.1016/j.gene.2014.02.026

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  42 in total

Review 1.  The Nox family of NAD(P)H oxidases: host defense and beyond.

Authors:  Miklós Geiszt; Thomas L Leto
Journal:  J Biol Chem       Date:  2004-09-13       Impact factor: 5.157

2.  Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site.

Authors:  Steve Bonello; Christian Zähringer; Rachida S BelAiba; Talija Djordjevic; John Hess; Carine Michiels; Thomas Kietzmann; Agnes Görlach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-01       Impact factor: 8.311

Review 3.  Biological roles for the NOX family NADPH oxidases.

Authors:  William M Nauseef
Journal:  J Biol Chem       Date:  2008-04-17       Impact factor: 5.157

4.  NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.

Authors:  Ioan Cucoranu; Roza Clempus; Anna Dikalova; Patrick J Phelan; Srividya Ariyan; Sergey Dikalov; Dan Sorescu
Journal:  Circ Res       Date:  2005-09-22       Impact factor: 17.367

5.  Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β.

Authors:  Marie-Jeanne Pierrat; Véronique Marsaud; Alain Mauviel; Delphine Javelaud
Journal:  J Biol Chem       Date:  2012-04-11       Impact factor: 5.157

Review 6.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

Authors:  Karen Bedard; Karl-Heinz Krause
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

7.  Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration.

Authors:  Mounir J Haurani; M Eugenia Cifuentes; Alexander D Shepard; Patrick J Pagano
Journal:  Hypertension       Date:  2008-05-12       Impact factor: 10.190

8.  Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature.

Authors:  Manish Mittal; Markus Roth; Peter König; Simone Hofmann; Eva Dony; Parag Goyal; Anne-Christin Selbitz; Ralph Theo Schermuly; Hossein Ardeschir Ghofrani; Grazyna Kwapiszewska; Wolfgang Kummer; Walter Klepetko; Mir Ali Reza Hoda; Ludger Fink; Jörg Hänze; Werner Seeger; Friedrich Grimminger; Harald H H W Schmidt; Norbert Weissmann
Journal:  Circ Res       Date:  2007-06-21       Impact factor: 17.367

9.  Positive regulation of the NADPH oxidase NOX4 promoter in vascular smooth muscle cells by E2F.

Authors:  Li Zhang; Olivia R Sheppard; Ajay M Shah; Alison C Brewer
Journal:  Free Radic Biol Med       Date:  2008-05-29       Impact factor: 7.376

10.  EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death.

Authors:  Irene Carmona-Cuenca; Blanca Herrera; Juan-José Ventura; César Roncero; Margarita Fernández; Isabel Fabregat
Journal:  J Cell Physiol       Date:  2006-05       Impact factor: 6.384

View more
  26 in total

1.  Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: LINKING CYTOSKELETAL ORGANIZATION TO REDOX STATE.

Authors:  Matthew Rozycki; Janne Folke Bialik; Pam Speight; Qinghong Dan; Teresa E T Knudsen; Stephen G Szeto; Darren A Yuen; Katalin Szászi; Stine F Pedersen; András Kapus
Journal:  J Biol Chem       Date:  2015-11-10       Impact factor: 5.157

2.  ENERGY SENSING PATHWAYS IN AGING AND CHRONIC LUNG DISEASE.

Authors:  Victor J Thannickal
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

3.  NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis.

Authors:  Andrey Lozhkin; Aleksandr E Vendrov; Hua Pan; Samuel A Wickline; Nageswara R Madamanchi; Marschall S Runge
Journal:  J Mol Cell Cardiol       Date:  2016-12-14       Impact factor: 5.000

4.  Endothelial cell tumor growth is Ape/ref-1 dependent.

Authors:  Ayan Biswas; Savita Khanna; Sashwati Roy; Xueliang Pan; Chandan K Sen; Gayle M Gordillo
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-24       Impact factor: 4.249

5.  Smad-independent pathway involved in transforming growth factor β1-induced Nox4 expression and proliferation of endothelial cells.

Authors:  Nora Y Hakami; Henry Wong; Manisha H Shah; Gregory J Dusting; Fan Jiang; Hitesh M Peshavariya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-27       Impact factor: 3.000

6.  Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor β.

Authors:  Sonsoles Piera-Velazquez; Alma Makul; Sergio A Jiménez
Journal:  Arthritis Rheumatol       Date:  2015-10       Impact factor: 10.995

7.  Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.

Authors:  Ahmed Bettaieb; Joy X Jiang; Yu Sasaki; Tzu-I Chao; Zsofia Kiss; Xiangling Chen; Jijing Tian; Masato Katsuyama; Chihiro Yabe-Nishimura; Yannan Xi; Cedric Szyndralewiez; Kathrin Schröder; Ajay Shah; Ralph P Brandes; Fawaz G Haj; Natalie J Török
Journal:  Gastroenterology       Date:  2015-04-14       Impact factor: 22.682

Review 8.  Regulation of NADPH oxidases in skeletal muscle.

Authors:  Leonardo F Ferreira; Orlando Laitano
Journal:  Free Radic Biol Med       Date:  2016-05-13       Impact factor: 7.376

9.  Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.

Authors:  Hadi Khalil; Onur Kanisicak; Vikram Prasad; Robert N Correll; Xing Fu; Tobias Schips; Ronald J Vagnozzi; Ruijie Liu; Thanh Huynh; Se-Jin Lee; Jason Karch; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2017-09-11       Impact factor: 14.808

Review 10.  Paradoxical roles of dual oxidases in cancer biology.

Authors:  Andrew C Little; Arvis Sulovari; Karamatullah Danyal; David E Heppner; David J Seward; Albert van der Vliet
Journal:  Free Radic Biol Med       Date:  2017-05-31       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.